Search
Search Results
-
Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE)
PurposeAn international survey was conducted by the Cardiovascular Interventional Radiological Society of Europe (CIRSE) to evaluate...
-
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
BackgroundUsing data collected in the prospective observational study CIRSE Registry for SIR-Spheres Therapy, the present study aimed at identifying...
-
Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization
PurposeAim of this study was to investigate a dose-response relationship, dose-toxicity relationship, progression free survival (PFS) and overall...
-
Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial
AimTo investigate the impact of pentoxifylline (PTX, 3 × 400 mg per day) and ursodeoxycholic acid (UDCA, 3 × 250 mg per day) administered for...
-
Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review
PurposeStrategies for the treatment of liver metastases from colon cancer (lmCRC) are constantly evolving. Radioembolization with yttrium 90 (Y-90...
-
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies
PurposeTransarterial radioembolization (TARE) with Yttrium-90 resin microspheres is a treatment option for patients with intrahepatic...
-
Trans-arterial Radioembolization Dosimetry in 2022
Trans-arterial radioembolization is currently performed using 90 Y-loaded glass or resin microspheres and also using 166 Ho-loaded microspheres. The...
-
Interventionelle Therapie bei endokrinen und neuroendokrinen Tumoren
BackgroundNeuroendocrine tumors (NET) are rare tumor entities that often have a good prognosis even in metastatic disease. NET patients with multiple...
-
-
Role of Radioembolization in Metastatic Neuroendocrine Tumors
The liver is the most common site of metastasis for neuroendocrine tumors originating from the gastrointestinal tract. Neuroendocrine liver...
-
Interventional Management of Portal Hypertension in Cancer Patients
Purpose of ReviewTo provide an overview of the classifications and clinical hallmarks of common cancer-related conditions that contribute to the high...
-
Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases
BackgroundIn radioembolization, response is achieved through the irradiation and damaging of tumor DNA. For hepatic metastases of neuroendocrine...
-
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
BackgroundTo confirm the prognostic value of previously published baseline interleukin 6 (IL6) and IL8 cutoff values in survival and liver...
-
Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma
BackgroundThe aim of this study was to investigate the safety and efficacy of selective internal radiation therapy (SIRT) with 90 Y resin...
-
MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review
Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide and within the United States. Liver transplant or partial liver resection...
-
Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma
Transarterial radioembolization with yttrium-90 microspheres is an established therapy for hepatocellular carcinoma. Post-procedural imaging is...
-
Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer
PurposeTo evaluate the benefit of a contrast-enhanced computed tomography (CT) radiomics-based model for predicting response and survival in patients...
-
Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
BackgroundFor safe and effective holmium-166 ( 166 Ho) liver radioembolization, dosimetry is crucial and requires accurate healthy liver definition....
